Skip to content

Study of the Aortic and Large Arterial Vessel Infections

French Registry Studying the Characteristics and Prognosis of Aortic and Large Arterial Vessel Infections

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05660733
Acronym
Repia
Enrollment
500
Registered
2022-12-21
Start date
2023-06-30
Completion date
2027-01-01
Last updated
2025-08-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Aortic Infections and Inflammations, Arterial Infections and Inflammations, Mycotic Aneurysm, Prosthetic Infection

Brief summary

Aortic or large arterial vessel infections are rare but serious infections. Their management is based on French and American expert opinions. The quality of evidence supporting these guidelines is low because most publications on the subject correspond to case series and few interventional studies have been performed to validate their management. However, referral centres for vascular surgery are frequently solicited to give their opinion on patients suffering from mycotic aneurysms. In addition, the last few decades have seen the improvement of vascular surgery techniques allowing the management of more and more patients, often elderly and comorbid. There has therefore been an increase in the incidence of infectious complications associated with this care. It is therefore essential to participate in research on aortic and large arterial vessel infections. For this, a monocentric cohort study seems to be an essential first step to better understand the polymorphism and complexity of these patients.

Interventions

None listed

Sponsors

Central Hospital, Nancy, France
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Age ≥ 18 years * Aortic or large arterial vessel infection. The diagnosis is made on a number of criteria in favour of the diagnosis (at least 2 of the following 3 criteria): * Compatible clinical presentation: local or general inflammatory signs suggestive of a deep infection (fever, chills, scar discharge, fistula, febrile abdominal pain and low back pain, ...) or per-operative finding of an infection in contact with native or prosthetic vascular tissue * And/or biological (inflammatory syndrome) and/or imaging evidence (infectious sign on native, bioprosthetic or prosthetic vascular tissue on CT and/or PET scan) in favour of the diagnosis * And/or microbiological evidence (positive serologies, blood cultures or deep samples in favour of infection)

Exclusion criteria

* Patient who objected to participation in this protocol and data collection * Pregnant woman, parturient or breastfeeding mother * Person deprived of liberty by a judicial or administrative decision, * Person subject to psychiatric care by virtue of articles L.3212-1 and L.3213-1 of the French public health code * Person subject to a legal protection measure * Person unable to give consent

Design outcomes

Primary

MeasureTime frameDescription
one-year mortalityone year after the diagnosisStudy of all-cause mortality in patients with aortic vascular infection and large arterial vessels during the first year of follow-up after diagnosis.

Secondary

MeasureTime frameDescription
Identification of prognostic factors associated with arterial vascular infectionsat the time of diagnosis and up to one year afterwardsIdentification of prognostic factors in patients with aortic and large arterial vessel infection: a multivariate Cox model to identify factors associated with mortality or better survival

Countries

France

Contacts

Primary ContactLefèvre Benjamin, M.D.
b.lefevre@chru-nancy.fr+33383157654

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 5, 2026